Brachytherapy attains abscopal effects when combined with immunostimulatory monoclonal antibodies.


PURPOSE/OBJECTIVES Preclinical and clinical evidence indicate that the proimmune effects of radiotherapy can be synergistically augmented with immunostimulatory monoclonal antibodies (mAb) to act both on irradiated tumor lesions and on tumors at distant, nonirradiated sites. We have recently reported that external beam radiotherapy achieves abscopal effects… (More)
DOI: 10.1016/j.brachy.2017.06.012


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics